August 25, 2016 11:27 AM ET

Biotechnology

Company Overview of Ambrilia Biopharma, Inc.

Executive Profile

Phil Gold M.D., Ph.D., CC, OQ, FRS(C), FRCP(C)

Chairman of Scientific Advisory Board, Ambrilia Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 5 different industries.

See Board Relationships
75--

Background

Dr. Phil Gold, M.D., Ph.D., CC, OQ, FRS(C), FRCP(C) serves as a Professor of Medicine, Physiology and Oncology McGill University. Dr. Gold has been an Executive Director of the Clinical Research Centre at the Montreal General Hospital Research Institute since 1995. He serves as an Executive Director of the Clinical Research Centre of the McGill University Health Centre. From 1980 to 1984, Dr. Gold was a Physician-in-Chief of the Montreal General Hospital. He serves as ...

Corporate Headquarters

1010 Sherbrooke Street
Montreal, Quebec H3A 2R7

Canada

Phone: 514-751-2003
Fax: 514-751-2502

Board Members Memberships

Chairman of the Board
Director
Director
2001-Present
Chairman of Scientific Advisory Board and Director

Education

MS 1961
McGill University
PhD 1965
McGill University
BS 1957
McGill University
MD 1961
McGill University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ambrilia Biopharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.